# Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer

> **NCT03101579** · PHASE1 · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 13 (actual)

## Conditions studied

- Leptomeningeal Metastases

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Dexamethasone
- **DRUG:** Folic Acid
- **DRUG:** Vitamin B12

## Key facts

- **NCT ID:** NCT03101579
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-09-15
- **Final completion:** 2019-01-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101579, "Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03101579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*